Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN

NCT07548385 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT07548385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 3
Overall status
Recruiting
Start date
April 30, 2026
Completion date
February 23, 2027
Enrollment
235 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative pain, total knee replacement surgery